# Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

> **NCT01380704** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 51 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** ABT-436
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT01380704
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2017-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380704, "Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01380704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*